Dr Anna Kilbey

  • Research Associate (Immunoprofiling FACS Specialist) (Institute of Cancer Sciences)
  • Associate (School of Veterinary Medicine)

telephone: 01413305608
email: Anna.Kilbey@glasgow.ac.uk

Publications

List by: Type | Date

Jump to: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2010 | 2009 | 2008 | 2007 | 2003 | 2001 | 1995
Number of items: 19.

2019

Hay, J. , Gilroy, K., Huser, C. , Kilbey, A., Mcdonald, A., MacCallum, A., Holroyd, A. , Cameron, E. and Neil, J. C. (2019) Collaboration of MYC and RUNX2 in lymphoma simulates T‐cell receptor signaling and attenuates p53 pathway activity. Journal of Cellular Biochemistry, 120(10), pp. 18332-18345. (doi:10.1002/jcb.29143) (PMID:31257681) (PMCID:PMC6772115)

2018

Anderson, G. et al. (2018) RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins. Journal of Cellular Biochemistry, 119(3), pp. 2750-2762. (doi:10.1002/jcb.26443) (PMID:29052866) (PMCID:PMC5813226)

2017

Kilbey, A. et al. (2017) Runx1 orchestrates sphingolipid metabolism and glucocorticoid resistance in lymphomagenesis. Journal of Cellular Biochemistry, 118(6), pp. 1432-1441. (doi:10.1002/jcb.25802) (PMID:27869314) (PMCID:5408393)

Neil, J. C. , Gilroy, K., Borland, G., Hay, J. , Terry, A. and Kilbey, A. (2017) The RUNX genes as conditional oncogenes: insights from retroviral targeting and mouse models. In: Groner, Y., Ito, Y., Liu, P., Neil, J. C., Speck, N. A. and van Wijnen, A. (eds.) RUNX Proteins in Development and Cancer. Series: Advances in experimental medicine and biology (962). Springer, pp. 247-264. ISBN 9789811032318 (doi:10.1007/978-981-10-3233-2_16)

Terry, A., Kilbey, A., Naseer, A., Levy, L. S., Ahmad, S., Watts, C., Mackay, N., Cameron, E. , Wilson, S. and Neil, J. C. (2017) Barriers to infection of human cells by feline leukemia virus: insights into resistance to zoonosis. Journal of Virology, 91(5), e02119-16. (doi:10.1128/JVI.02119-16) (PMID:28031367) (PMCID:PMC5309941)

2016

Neil, J. C. , Borland, G. and Kilbey, A. (2016) Addiction to RUNX in lymphoma. Aging, 8(9), pp. 1832-1833. (doi:10.18632/aging.101071) (PMID:27688195) (PMCID:PMC5076437)

Gilroy, K. L. et al. (2016) Gamma-retrovirus integration marks cell type-specific cancer genes: a novel profiling tool in cancer genomics. PLoS ONE, 11(4), e0154070. (doi:10.1371/journal.pone.0154070) (PMID:27097319) (PMCID:PMC4838236)

Borland, G. et al. (2016) Addiction to Runx1 is partially attenuated by loss of p53 in the Eμ-Myc lymphoma model. Oncotarget, 7(17), pp. 22973-22987. (doi:10.18632/oncotarget.8554) (PMID:27056890) (PMCID:PMC5029604)

2015

Naseer, A. et al. (2015) Frequent infection of human cancer xenografts with murine endogenous retroviruses in vivo. Viruses, 7(4), pp. 2014-2029. (doi:10.3390/v7042014) (PMID:25912714) (PMCID:PMC4411688)

2014

Huser, C. A. et al. (2014) Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc/p53-dependent bottleneck in lymphomagenesis. PLoS Genetics, 10(2), e1004167. (doi:10.1371/journal.pgen.1004167) (PMID:24586197) (PMCID:PMC3937229)

2010

Kilbey, A., Terry, A., Jenkins, A., Borland, G., Zhang, Q.F., Wakelam, M.J.O., Cameron, E.R. and Neil, J.C. (2010) Runx regulation of sphingolipid metabolism and survival signaling. Cancer Research, 70(14), pp. 5860-5869. (doi:10.1158/0008-5472.CAN-10-0726)

Krapf, G., Kaindl, U., Kilbey, A., Fuka, G., Inthal, A., Joas, R., Mann, G., Neil, J.C. , Haas, O.A. and Panzer-Grümayer, E.R. (2010) ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1. Oncogene, 29(22), pp. 3307-3312. (doi:10.1038/onc.2010.53)

2009

Wolyniec, K., Wotton, S., Kilbey, A., Jenkins, A., Terry, A., Peters, G., Stocking, C., Cameron, E.R. and Neil, J.C. (2009) RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress. Oncogene, 28(27), pp. 2502-2512. (doi:10.1038/onc.2009.101)

2008

Wotton, S., Terry, A., Kilbey, A., Jenkins, A., Herzyk, P. , Cameron, E. and Neil, J.C. (2008) Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival. Oncogene, 27(44), pp. 5856-5866. (doi:10.1038/onc.2008.195)

Kilbey, A., Terry, A., Cameron, E.R. and Neil, J.C. (2008) Oncogene-induced senescence: an essential role for Runx. Cell Cycle, 7(15), pp. 2333-2340.

2007

Kilbey, A., Blyth, K. , Wotton, S., Terry, A., Jenkins, A., Bell, M., Hanlon, L., Cameron, E.R. and Neil, J.C. (2007) Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts. Cancer Research, 67(23), pp. 11263-11271. (doi:10.1158/0008-5472.CAN-07-3016)

2003

Cameron, E. R., Blyth, K. , Hanlon, L., Kilbey, A., Mackay, N., Stewart, M., Terry, A., Vaillant, F., Wotton, S. and Neil, J. C. (2003) The Runx genes as dominant oncogenes. Blood Cells, Molecules, and Diseases, 30, pp. 194-200. (doi:10.1016/S1079-9796(03)00031-7)

2001

Palmer, S., Brouillet, J.-P., Kilbey, A., Fulton, R., Walker, M., Crossley, M. and Bartholomew, C. (2001) Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins. Journal of Biological Chemistry, 276(28), pp. 25834-25840. (doi:10.1074/jbc.M102343200)

1995

Barnett, S. C. , Rosario, M., Doyle, A., Kilbey, A., Lovatt, A. and Gillespie, D. A.F. (1995) Differential regulation of AP-1 and novel TRE-specific DNA-binding complexes during differentiation of oligodendrocyte-type-2-astrocyte (O-2A) progenitor cells. Development, 121(12), pp. 3969-77. (PMID:8575297)

This list was generated on Sat Dec 14 20:22:18 2019 GMT.
Number of items: 19.

Articles

Hay, J. , Gilroy, K., Huser, C. , Kilbey, A., Mcdonald, A., MacCallum, A., Holroyd, A. , Cameron, E. and Neil, J. C. (2019) Collaboration of MYC and RUNX2 in lymphoma simulates T‐cell receptor signaling and attenuates p53 pathway activity. Journal of Cellular Biochemistry, 120(10), pp. 18332-18345. (doi:10.1002/jcb.29143) (PMID:31257681) (PMCID:PMC6772115)

Anderson, G. et al. (2018) RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins. Journal of Cellular Biochemistry, 119(3), pp. 2750-2762. (doi:10.1002/jcb.26443) (PMID:29052866) (PMCID:PMC5813226)

Kilbey, A. et al. (2017) Runx1 orchestrates sphingolipid metabolism and glucocorticoid resistance in lymphomagenesis. Journal of Cellular Biochemistry, 118(6), pp. 1432-1441. (doi:10.1002/jcb.25802) (PMID:27869314) (PMCID:5408393)

Terry, A., Kilbey, A., Naseer, A., Levy, L. S., Ahmad, S., Watts, C., Mackay, N., Cameron, E. , Wilson, S. and Neil, J. C. (2017) Barriers to infection of human cells by feline leukemia virus: insights into resistance to zoonosis. Journal of Virology, 91(5), e02119-16. (doi:10.1128/JVI.02119-16) (PMID:28031367) (PMCID:PMC5309941)

Neil, J. C. , Borland, G. and Kilbey, A. (2016) Addiction to RUNX in lymphoma. Aging, 8(9), pp. 1832-1833. (doi:10.18632/aging.101071) (PMID:27688195) (PMCID:PMC5076437)

Gilroy, K. L. et al. (2016) Gamma-retrovirus integration marks cell type-specific cancer genes: a novel profiling tool in cancer genomics. PLoS ONE, 11(4), e0154070. (doi:10.1371/journal.pone.0154070) (PMID:27097319) (PMCID:PMC4838236)

Borland, G. et al. (2016) Addiction to Runx1 is partially attenuated by loss of p53 in the Eμ-Myc lymphoma model. Oncotarget, 7(17), pp. 22973-22987. (doi:10.18632/oncotarget.8554) (PMID:27056890) (PMCID:PMC5029604)

Naseer, A. et al. (2015) Frequent infection of human cancer xenografts with murine endogenous retroviruses in vivo. Viruses, 7(4), pp. 2014-2029. (doi:10.3390/v7042014) (PMID:25912714) (PMCID:PMC4411688)

Huser, C. A. et al. (2014) Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc/p53-dependent bottleneck in lymphomagenesis. PLoS Genetics, 10(2), e1004167. (doi:10.1371/journal.pgen.1004167) (PMID:24586197) (PMCID:PMC3937229)

Kilbey, A., Terry, A., Jenkins, A., Borland, G., Zhang, Q.F., Wakelam, M.J.O., Cameron, E.R. and Neil, J.C. (2010) Runx regulation of sphingolipid metabolism and survival signaling. Cancer Research, 70(14), pp. 5860-5869. (doi:10.1158/0008-5472.CAN-10-0726)

Krapf, G., Kaindl, U., Kilbey, A., Fuka, G., Inthal, A., Joas, R., Mann, G., Neil, J.C. , Haas, O.A. and Panzer-Grümayer, E.R. (2010) ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1. Oncogene, 29(22), pp. 3307-3312. (doi:10.1038/onc.2010.53)

Wolyniec, K., Wotton, S., Kilbey, A., Jenkins, A., Terry, A., Peters, G., Stocking, C., Cameron, E.R. and Neil, J.C. (2009) RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress. Oncogene, 28(27), pp. 2502-2512. (doi:10.1038/onc.2009.101)

Wotton, S., Terry, A., Kilbey, A., Jenkins, A., Herzyk, P. , Cameron, E. and Neil, J.C. (2008) Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival. Oncogene, 27(44), pp. 5856-5866. (doi:10.1038/onc.2008.195)

Kilbey, A., Terry, A., Cameron, E.R. and Neil, J.C. (2008) Oncogene-induced senescence: an essential role for Runx. Cell Cycle, 7(15), pp. 2333-2340.

Kilbey, A., Blyth, K. , Wotton, S., Terry, A., Jenkins, A., Bell, M., Hanlon, L., Cameron, E.R. and Neil, J.C. (2007) Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts. Cancer Research, 67(23), pp. 11263-11271. (doi:10.1158/0008-5472.CAN-07-3016)

Cameron, E. R., Blyth, K. , Hanlon, L., Kilbey, A., Mackay, N., Stewart, M., Terry, A., Vaillant, F., Wotton, S. and Neil, J. C. (2003) The Runx genes as dominant oncogenes. Blood Cells, Molecules, and Diseases, 30, pp. 194-200. (doi:10.1016/S1079-9796(03)00031-7)

Palmer, S., Brouillet, J.-P., Kilbey, A., Fulton, R., Walker, M., Crossley, M. and Bartholomew, C. (2001) Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins. Journal of Biological Chemistry, 276(28), pp. 25834-25840. (doi:10.1074/jbc.M102343200)

Barnett, S. C. , Rosario, M., Doyle, A., Kilbey, A., Lovatt, A. and Gillespie, D. A.F. (1995) Differential regulation of AP-1 and novel TRE-specific DNA-binding complexes during differentiation of oligodendrocyte-type-2-astrocyte (O-2A) progenitor cells. Development, 121(12), pp. 3969-77. (PMID:8575297)

Book Sections

Neil, J. C. , Gilroy, K., Borland, G., Hay, J. , Terry, A. and Kilbey, A. (2017) The RUNX genes as conditional oncogenes: insights from retroviral targeting and mouse models. In: Groner, Y., Ito, Y., Liu, P., Neil, J. C., Speck, N. A. and van Wijnen, A. (eds.) RUNX Proteins in Development and Cancer. Series: Advances in experimental medicine and biology (962). Springer, pp. 247-264. ISBN 9789811032318 (doi:10.1007/978-981-10-3233-2_16)

This list was generated on Sat Dec 14 20:22:18 2019 GMT.